Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call

Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results
and Host 2014 Strategy Conference Call

Conference Call Scheduled for Monday, March 3, at 8:30 a.m. Eastern Time

HAMPTON, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc.
(Nasdaq:CLDX) will release fourth quarter and year end 2013 financial results
on Monday, March 3, 2014 before the U.S. financial markets open. Celldex
executives will host a conference call at 8:30 a.m. ET on the same day to
discuss 2013 financial and business results and to provide an update on key
2014 objectives.

The conference call and presentation will be webcast live over the Internet
and can be accessed by going to the "Events & Presentations" page under the
"Investors & Media" section of the Celldex Therapeutics website at
www.celldex.com. The call can also be accessed by dialing (866) 743-9666
(within the United States) or (760) 298-5103 (outside the United States). The
passcode is 39634623.

A replay of the call will be available approximately two hours after the live
call concludes through March 10, 2014. To access the replay, dial (855)
859-2056 (within the United States) or (404) 537-3406 (outside the United
States). The passcode is 39634623. The webcast will also be archived on the
Company's website.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline is built from a
proprietary portfolio of antibodies and immunomodulators used alone and in
strategic combinations to create novel, disease-specific therapies that
induce, enhance or suppress the body's immune response. Visit www.celldex.com.

CONTACT: Sarah Cavanaugh
         Vice President of Investor Relations &
         Corp Communications
         Celldex Therapeutics, Inc.
         (781) 433-3161
         scavanaugh@celldex.com
 
Press spacebar to pause and continue. Press esc to stop.